Healthcare Industry News: Biostat
News Release - March 21, 2007
Spinal Restoration, Inc. Names Gary E. Sabins as President and CEOProven Medical Technology Executive and Entrepreneur Leads Start-up Venture, Builds Management Team
AUSTIN, Texas--(HSMN NewsFeed)--Gary Sabins has been named the president and CEO of Spinal Restoration, Inc. a privately held, venture backed medical technology company that specializes in the early intervention of chronic back pain. Spinal Restoration is focused on developing a new biologic treatment for discogenic pain, a condition which accounts for approximately 4 million patients annually that suffers from chronic low back pain. The company's first product, the Biostat(TM) Disc Augmentation System, will be the subject of an IDE clinical trial expected to begin in early 2008.
Mr. Sabins has recently been a business consultant and entrepreneur having launched or assisted several successful companies. Previously, Mr. Sabins was the President of Sulzer Orthopedics, Inc. a global medical device company with annual sales in excess of half a billion dollars. He directed a world wide organization with over 1800 employees. During his tenure at Sulzer Orthopedics, he grew their revenue from $80MM to over $650MM during an 8 year period.
Regarding his new role at Spinal Restoration, Sabins commented, "Improving the quality of life through advancing medical technologies has always been a passion for me. To be engaged with a company that can truly help people with their back pain is extremely motivating. Spinal Restoration's technology is very elegant and exciting, and we have the opportunity to dramatically change the way back pain is managed, giving people a chance to restore the quality of their lives."
In the coming months, Sabins will continue to build his executive team and expand the company's Clinical and Scientific Advisory Boards to begin the regulatory approval process for the company's products. Mr. Sabins is also working to develop and strengthen Spinal Restoration's partnerships in key areas such as suppliers, design, development, manufacturing, clinical research and intellectual property.
Sabins closes by saying, "Spinal Restoration has the ability to change the landscape of back pain care. The opportunity to lead this company was too great to pass up - I knew I wanted to be involved with what may be a "game-changing technology." We anticipate having some exciting things to announce in the coming months and I am honored to lead this effort. We are committed and confident, that through our work, we will help restore patients' lives."
About Spinal Restoration: Spinal Restoration restores patients' lives by delivering new therapies that address unmet needs in spine health management. These therapies are minimally invasive, early interventions with clinically proven results. The company is working with a diverse, highly regarded group of clinical and scientific advisors to develop the Biostat(TM) Disc Augmentation System, a proprietary resorbable biologic and delivery system for the treatment of chronic disc pain.
Please visit the company on the web at: www.spinalrestoration.com
Source: Spinal Restoration
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.